Lord, Abbett & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-197,668
| Closed | -$95.4M | – | 575 |
|
2022
Q2 | $95.4M | Buy |
+197,668
| New | +$95.4M | 0.34% | 76 |
|
2020
Q4 | – | Sell |
-116,241
| Closed | -$31.2M | – | 666 |
|
2020
Q3 | $31.2M | Sell |
116,241
-29,499
| -20% | -$7.92M | 0.1% | 297 |
|
2020
Q2 | $38.3M | Sell |
145,740
-45,376
| -24% | -$11.9M | 0.13% | 245 |
|
2020
Q1 | $43.4M | Sell |
191,116
-20,874
| -10% | -$4.74M | 0.19% | 164 |
|
2019
Q4 | $64M | Sell |
211,990
-13,328
| -6% | -$4.03M | 0.21% | 140 |
|
2019
Q3 | $54.1M | Sell |
225,318
-6,511
| -3% | -$1.56M | 0.18% | 172 |
|
2019
Q2 | $65.4M | Buy |
231,829
+155
| +0.1% | +$43.7K | 0.21% | 158 |
|
2019
Q1 | $66.5M | Sell |
231,674
-8,169
| -3% | -$2.34M | 0.22% | 139 |
|
2018
Q4 | $63M | Buy |
239,843
+216,143
| +912% | +$56.8M | 0.23% | 129 |
|
2018
Q3 | $6.5M | Buy |
23,700
+8,700
| +58% | +$2.38M | 0.02% | 696 |
|
2018
Q2 | $3.57M | Buy |
+15,000
| New | +$3.57M | 0.01% | 782 |
|
2017
Q2 | – | Sell |
-211,100
| Closed | -$34.9M | – | 891 |
|
2017
Q1 | $34.9M | Sell |
211,100
-43,700
| -17% | -$7.23M | 0.1% | 304 |
|
2016
Q4 | $36.6M | Sell |
254,800
-36,700
| -13% | -$5.28M | 0.11% | 273 |
|
2016
Q3 | $36.5M | Buy |
291,500
+95,500
| +49% | +$12M | 0.11% | 293 |
|
2016
Q2 | $25.7M | Buy |
196,000
+162,300
| +482% | +$21.3M | 0.08% | 361 |
|
2016
Q1 | $4.68M | Sell |
33,700
-5,100
| -13% | -$709K | 0.01% | 716 |
|
2015
Q4 | $5.41M | Buy |
38,800
+14,500
| +60% | +$2.02M | 0.02% | 721 |
|
2015
Q3 | $3.4M | Sell |
24,300
-45,300
| -65% | -$6.34M | 0.01% | 794 |
|
2015
Q2 | $11.4M | Buy |
69,600
+1,400
| +2% | +$230K | 0.03% | 617 |
|
2015
Q1 | $10.5M | Buy |
68,200
+7,700
| +13% | +$1.19M | 0.03% | 614 |
|
2014
Q4 | $7.6M | Buy |
+60,500
| New | +$7.6M | 0.02% | 654 |
|
2013
Q3 | – | Sell |
-156,900
| Closed | -$12.8M | – | 1043 |
|
2013
Q2 | $12.8M | Buy |
+156,900
| New | +$12.8M | 0.03% | 585 |
|